106 related articles for article (PubMed ID: 17085097)
1. What's the trouble with cytology?
Murphy WM
J Urol; 2006 Dec; 176(6 Pt 1):2343-6. PubMed ID: 17085097
[No Abstract] [Full Text] [Related]
2. [The value of urine cytology in the diagnosis of primary and recurrent urotheliomas].
Truss F
Med Welt; 1983 Mar; 34(11):337-41. PubMed ID: 6843332
[No Abstract] [Full Text] [Related]
3. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
4. [Combined cytology/cytometry for preventing misinterpretations of urine cytology].
vom Dorp F
Urologe A; 2007 Sep; 46(9):1140-1. PubMed ID: 17665165
[No Abstract] [Full Text] [Related]
5. Urine cytology in the detection of bladder tumor recurrence.
Orandi A; Orandi M
J Urol; 1976 Nov; 116(5):568-9. PubMed ID: 978807
[TBL] [Abstract][Full Text] [Related]
6. [Role of urinary cytology in the diagnosis and followup of bladder tumors. Review of 200 cases].
el Mezni F; Chebil M; Belhassine S; Zermani R; Jemni M; Ennigrou S; Ayed M; Ben Jilani S
Tunis Med; 1998 Dec; 76(12):475-80. PubMed ID: 10093489
[No Abstract] [Full Text] [Related]
7. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
8. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent extranodal B-cell (MALT) lymphoma of the urinary bladder].
Al'-Shukri SKh; Korneev IA; Boĭkov VV; Nevirovich ES; Kurnakov AM
Urologiia; 2006; (1):67-8. PubMed ID: 16550829
[No Abstract] [Full Text] [Related]
10. [Diagnosis of recurrences of bladder cancer].
Startsev VIu
Vopr Onkol; 2001; 47(5):536-43. PubMed ID: 11785092
[No Abstract] [Full Text] [Related]
11. [Bladder leiomyoma].
Derouiche A; Bouzouita A; Kourda N; Blah M; Bouassida A; Ben Jilani S; Chebil M
Tunis Med; 2008 Jun; 86(6):609-10. PubMed ID: 19216461
[No Abstract] [Full Text] [Related]
12. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
14. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
Yoder BJ; Skacel M; Hedgepeth R; Babineau D; Ulchaker JC; Liou LS; Brainard JA; Biscotti CV; Jones JS; Tubbs RR
Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520
[TBL] [Abstract][Full Text] [Related]
15. Urine test boosts detection of recurrent bladder cancer.
Hilton L
RN; 2006 Apr; 69(4):3-4. PubMed ID: 16640017
[No Abstract] [Full Text] [Related]
16. Biological markers in the diagnosis of recurrent bladder cancer: an overview.
Mohammed A; Khan Z; Zamora I; Bhatti A
Expert Rev Mol Diagn; 2008 Jan; 8(1):63-72. PubMed ID: 18088231
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining.
Herlitz LC; Tong GX; Hamele-Bena D; Greenebaum E
Diagn Cytopathol; 2008 Jan; 36(1):47-9. PubMed ID: 18064687
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
[TBL] [Abstract][Full Text] [Related]
19. Media hype in the medical literature: what's a doctor to do?
Murphy WM
J Urol; 2000 Mar; 163(3):916-8. PubMed ID: 10688015
[No Abstract] [Full Text] [Related]
20. [What do clinicians look for in urinary cytology?].
Zerbib M
Ann Pathol; 2000; 20 Suppl():S71-2. PubMed ID: 11261301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
